2092 Updated analysis: Observational cohort study of 1st line bevacizumab combined with chemotherapy in metastatic colorectal cancer (HGCSG0802): Comparison of infusional FU/oxaliplatin(OX)+BV and oral FU/OX+BV
Hiroshi Nakatsumi, Satoshi Yuki, Yasuyuki Kawamoto, Toshiya Muranaka, Kazuteru Hatanaka, Takashi Kato, T. Meguro, Michio Nakamura, Ichiro Iwanaga, Minoru Uebayashi, M. Tateyama, Kojiro Eto, Masatoshi Kudo, Seiya Kato, Hiroyuki Okuda, Susumu Sogabe, Kencho Miyashita, Yuh Sakata, Naoya Sakamoto, Yoshihiko Komatsu (2015). 2092 Updated analysis: Observational cohort study of 1st line bevacizumab combined with chemotherapy in metastatic colorectal cancer (HGCSG0802): Comparison of infusional FU/oxaliplatin(OX)+BV and oral FU/OX+BV. , 51, DOI: https://doi.org/10.1016/s0959-8049(16)31014-0.
